ARTICLE | Clinical News
Orencia abatacept regulatory update
November 1, 2010 7:00 AM UTC
Bristol-Myers disclosed in its 3Q10 earnings that Japan's Ministry of Health, Labor and Welfare approved an NDA in July for Orencia abatacept to treat rheumatoid arthritis. The CTLA-4 Ig fusion prote...